Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why AstraZeneca Stock Is Sliding Today

TheMotleyFool

0 0

Why AstraZeneca Stock Is Sliding Today: https://g.foolcdn.com/editorial/images/784596/scientist-looking-through-microscope.jpg

Shares of AstraZeneca (NASDAQ: AZN) were sliding 3.2% lower as of 10:57 a.m. ET on Thursday. The decline came after the British drugmaker announced its second-quarter results.

AstraZeneca reported total revenue in Q2 of $12.9 billion, up 13% year over year. This result topped the average analysts' revenue estimate of $12.6 billion.

The company posted earnings per share (EPS) of $1.24, a 6% year-over-year increase. Its core EPS, which excludes costs related to the amortization of intangibles, impairments, legal settlements, and restructuring charges, fell 8% to $1.98. Both earnings figures beat the average analysts' EPS estimate of $1.20.

Source Fool.com